HG-7-85-01, CAS [[1258391-13-7]]

Artikelnummer: TGM-T38653
Artikelname: HG-7-85-01, CAS [[1258391-13-7]]
Artikelnummer: TGM-T38653
Hersteller Artikelnummer: T38653
Alternativnummer: TGM-T38653-1MG,TGM-T38653-2MG,TGM-T38653-5MG,TGM-T38653-10MG,TGM-T38653-25MG,TGM-T38653-50MG,TGM-T38653-100MG
Hersteller: TargetMol
Kategorie: Biochemikalien
HG-7-85-01 is a novel ATP-competitive and type II tyrosine kinase inhibitor targeting both wild-type and watchman mutant BCR-ABL, PDGFRalpha, Kit, and Src kinases, with inhibitory effects on the proliferation of a variety of cancer cell lines, leading to G0/G1-phase blockade and apoptosis induction in BCR-ABL-expressing cells.
Molekulargewicht: 608.68
Reinheit: 98.08%
CAS Nummer: [1258391-13-7]
Formel: C31H31F3N6O2S
Target-Kategorie: Apoptosis|||JAK|||PDGFR|||c-Kit|||Src|||Bcr-Abl
T38653
T38653